Abstract
The pathogenesis of symptoms of the common cold and their optimal treatment are incompletely understood. To evaluate the role of an oral alpha agonist alone and in combination with a nonsteroidal anti-inflammatory drug in the treatment of experimental rhinovirus colds, 58 subjects were randomized to receive pseudoephedrine 60 mg alone, pseudoephedrine 60 mg plus ibuprofen 200 mg, or placebo, four times daily for 4 1/2 days beginning 30 hours after intranasal rhinovirus inoculation under double-blind conditions. The frequencies of infection, colds occurrence, and viral shedding did not differ significantly between the groups. Total symptom scores were reduced by 59% by pseudoephedrine plus ibuprofen (p less than 0.05) and 48% by pseudoephedrine alone compared with placebo. Nasal symptom scores tended to be lower in recipients of pseudoephedrine plus ibuprofen compared with pseudoephedrine alone (p = 0.09), but other parameters showed no significant treatment differences between the groups. Rhinorrhea, as determined by nasal secretion weights, was significantly reduced in both treatment groups compared to placebo. Nasal patency measurements tended to show the greatest improvement in recipients of pseudoephedrine plus ibuprofen. Therapy was clinically well tolerated. The results suggest that an oral alpha agonist is effective in modifying certain manifestations of experimental rhinovirus infection and that the addition of a nonsteroidal anti-inflammatory drug may provide additional benefit in nasal symptoms and patency. Studies involving large numbers of patients with natural colds are needed to determine the clinical significance of these findings.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bye C. E., Cooper J., Empey D. W., Fowle A. S., Hughes D. T., Letley E., O'Grady J. Effects of pseudoephedrine and triprolidine, alone and in combination, on symptoms of the common cold. Br Med J. 1980 Jul 19;281(6234):189–190. doi: 10.1136/bmj.281.6234.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cooper S. A., Needle S. E., Kruger G. O. Comparative analgesic potency of aspirin and ibuprofen. J Oral Surg. 1977 Nov;35(11):898–903. [PubMed] [Google Scholar]
- Dressler W. E., Myers T., Rankell A. S., London S. J., Poetsch C. E. A system of rhinomanometry in the clinical evaluation of nasal decongestants. Ann Otol Rhinol Laryngol. 1977 May-Jun;86(3 Pt 1):310–317. doi: 10.1177/000348947708600306. [DOI] [PubMed] [Google Scholar]
- Drew C. D., Knight G. T., Hughes D. T., Bush M. Comparison of the effects of D-(-)-ephedrine and L-(+)-pseudoephedrine on the cardiovascular and respiratory systems in man. Br J Clin Pharmacol. 1978 Sep;6(3):221–225. doi: 10.1111/j.1365-2125.1978.tb04588.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dubinsky B., Schupsky J. J. Mechanism of action of suprofen, a new peripheral analgesic, as demonstrated by its effects on several nociceptive mediators. Prostaglandins. 1984 Aug;28(2):241–252. doi: 10.1016/0090-6980(84)90060-1. [DOI] [PubMed] [Google Scholar]
- Eggleston P. A., Hendley J. O., Gwaltney J. M., Jr Mediators of immediate hypersensitivity in nasal secretions during natural colds and rhinovirus infection. Acta Otolaryngol Suppl. 1984;413:25–35. doi: 10.3109/00016488409128538. [DOI] [PubMed] [Google Scholar]
- Empey D. W., Young G. A., Letley E., John G. C., Smith P., McDonnell K. A., Bagg L. R., Hughes D. T. Dose-response study of the nasal decongestant and cardiovascular effects of pseudoephedrine. Br J Clin Pharmacol. 1980 Apr;9(4):351–358. doi: 10.1111/j.1365-2125.1980.tb01061.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Farr B. M., Gwaltney J. M., Jr, Adams K. F., Hayden F. G. Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds. Antimicrob Agents Chemother. 1984 Jul;26(1):31–34. doi: 10.1128/aac.26.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gaffey M. J., Gwaltney J. M., Jr, Dressler W. E., Sorrentino J. V., Hayden F. G. Intranasally administered atropine methonitrate treatment of experimental rhinovirus colds. Am Rev Respir Dis. 1987 Jan;135(1):241–244. doi: 10.1164/arrd.1987.135.1.241. [DOI] [PubMed] [Google Scholar]
- Gwaltney J. M., Jr, Moskalski P. B., Hendley J. O. Interruption of experimental rhinovirus transmission. J Infect Dis. 1980 Dec;142(6):811–815. doi: 10.1093/infdis/142.6.811. [DOI] [PubMed] [Google Scholar]
- Hayden F. G., Gwaltney J. M., Jr Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds. J Infect Dis. 1984 Aug;150(2):174–180. doi: 10.1093/infdis/150.2.174. [DOI] [PubMed] [Google Scholar]
- Hayden F. G., Gwaltney J. M., Jr Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infection. Antimicrob Agents Chemother. 1982 Jun;21(6):892–897. doi: 10.1128/aac.21.6.892. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hayden F. G., Kaiser D. L., Albrecht J. K. Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds. Antimicrob Agents Chemother. 1988 Feb;32(2):224–230. doi: 10.1128/aac.32.2.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heavey D. J., Barrow S. E., Hickling N. E., Ritter J. M. Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in man. Nature. 1985 Nov 14;318(6042):186–188. doi: 10.1038/318186a0. [DOI] [PubMed] [Google Scholar]
- Inoki R., Hayashi T., Kudo T., Matsumoto K. Effects of aspirin and morphine on the release of a bradykinin-like substance into the subcutaneous perfusate of the rat paw. Pain. 1978 Jun;5(1):53–63. doi: 10.1016/0304-3959(78)90024-6. [DOI] [PubMed] [Google Scholar]
- Koopmans P. P., Thien T., Gribnau F. W. The influence of ibuprofen, diclofenac and sulindac on the blood pressure lowering effect of hydrochlorothiazide. Eur J Clin Pharmacol. 1987;31(5):553–557. doi: 10.1007/BF00606629. [DOI] [PubMed] [Google Scholar]
- Maderazo E. G., Breaux S. P., Woronick C. L. Inhibition of human polymorphonuclear leukocyte cell responses by ibuprofen. J Pharm Sci. 1984 Oct;73(10):1403–1406. doi: 10.1002/jps.2600731020. [DOI] [PubMed] [Google Scholar]
- Maderazo E. G., Breaux S. P., Woronick C. L. Protective effects of ibuprofen and methylprednisolone on chemotactic factor-induced transcutaneous hypoxia. J Pharmacol Exp Ther. 1986 Aug;238(2):453–456. [PubMed] [Google Scholar]
- McKenney J. M., Wright J. T., Jr, Goodman R. P., Cooper L., Yunker N., Lambert C. Effect of high-dose ibuprofen on 24-hour blood pressure in healthy women. Drug Intell Clin Pharm. 1987 Jun;21(6):517–521. doi: 10.1177/106002808702100608. [DOI] [PubMed] [Google Scholar]
- Naclerio R. M., Proud D., Lichtenstein L. M., Kagey-Sobotka A., Hendley J. O., Sorrentino J., Gwaltney J. M. Kinins are generated during experimental rhinovirus colds. J Infect Dis. 1988 Jan;157(1):133–142. doi: 10.1093/infdis/157.1.133. [DOI] [PubMed] [Google Scholar]
- Nielsen V. G., Webster R. O. Inhibition of human polymorphonuclear leukocyte functions by ibuprofen. Immunopharmacology. 1987 Feb;13(1):61–71. doi: 10.1016/0162-3109(87)90027-0. [DOI] [PubMed] [Google Scholar]
- Pentel P. Toxicity of over-the-counter stimulants. JAMA. 1984 Oct 12;252(14):1898–1903. [PubMed] [Google Scholar]
- Perlman M. B., Johnson A., Malik A. B. Ibuprofen prevents thrombin-induced lung vascular injury: mechanism of effect. Am J Physiol. 1987 Mar;252(3 Pt 2):H605–H614. doi: 10.1152/ajpheart.1987.252.3.H605. [DOI] [PubMed] [Google Scholar]
- Phillpotts R. J., Tyrrell D. A. Rhinovirus colds. Br Med Bull. 1985 Oct;41(4):386–390. doi: 10.1093/oxfordjournals.bmb.a072081. [DOI] [PubMed] [Google Scholar]
- Phillpotts R. J., Wallace J., Tyrrell D. A., Tagart V. B. Therapeutic activity of enviroxime against rhinovirus infection in volunteers. Antimicrob Agents Chemother. 1983 May;23(5):671–675. doi: 10.1128/aac.23.5.671. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Radack K. L., Deck C. C., Bloomfield S. S. Ibuprofen interferes with the efficacy of antihypertensive drugs. A randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen. Ann Intern Med. 1987 Nov;107(5):628–635. doi: 10.7326/0003-4819-107-5-628. [DOI] [PubMed] [Google Scholar]
- Roth R. P., Cantekin E. I., Bluestone C. D., Welch R. M., Cho Y. W. Nasal decongestant activity of pseudoephedrine. Ann Otol Rhinol Laryngol. 1977 Mar-Apr;86(2 Pt 1):235–242. doi: 10.1177/000348947708600216. [DOI] [PubMed] [Google Scholar]
- Skubitz K. M., Hammerschmidt D. E. Effects of ibuprofen on chemotactic peptide-receptor binding and granulocyte response. Biochem Pharmacol. 1986 Oct 1;35(19):3349–3354. doi: 10.1016/0006-2952(86)90434-x. [DOI] [PubMed] [Google Scholar]
- Sperber S. J., Hayden F. G. Chemotherapy of rhinovirus colds. Antimicrob Agents Chemother. 1988 Apr;32(4):409–419. doi: 10.1128/aac.32.4.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stanley E. D., Jackson G. G., Panusarn C., Rubenis M., Dirda V. Increased virus shedding with aspirin treatment of rhinovirus infection. JAMA. 1975 Mar 24;231(12):1248–1251. [PubMed] [Google Scholar]
- Venezio F. R., DiVincenzo C., Pearlman F., Phair J. P. Effects of the newer nonsteroidal anti-inflammatory agents, ibuprofen, fenoprofen, and sulindac, on neutrophil adherence. J Infect Dis. 1985 Oct;152(4):690–694. doi: 10.1093/infdis/152.4.690. [DOI] [PubMed] [Google Scholar]
- Whalley E. T. Reduction in vivo of uterine responses to bradykinin by indomethacin in the rat. J Pharm Pharmacol. 1979 Jul;31(7):486–487. doi: 10.1111/j.2042-7158.1979.tb13565.x. [DOI] [PubMed] [Google Scholar]
- Winther B., Farr B., Turner R. B., Hendley J. O., Gwaltney J. M., Jr, Mygind N. Histopathologic examination and enumeration of polymorphonuclear leukocytes in the nasal mucosa during experimental rhinovirus colds. Acta Otolaryngol Suppl. 1984;413:19–24. doi: 10.3109/00016488409128537. [DOI] [PubMed] [Google Scholar]